The Market Reports

Synopsis
The global market for Fluorescence-Guided Surgery Systems was estimated to be worth US$ 125 million in 2024 and is forecast to a readjusted size of US$ 423 million by 2031 with a CAGR of 18.7% during the forecast period 2025-2031.
Fluorescence guided surgery (FGS), (also called 'Fluorescence image-guided surgery', or in the specific case of tumor resection, 'fluorescence guided resection') is a medical imaging technique used to detect fluorescently labelled structures during surgery. Similarly, to standard image-guided surgery, FGS has the purpose of guiding the surgical procedure and providing the surgeon of real time visualization of the operating field. When compared to other medical imaging modalities, FGS is cheaper and superior in terms of resolution and number of molecules detectable.
The fluorescence-guided surgery (FGS) systems market is primarily driven by the growing demand for more precise and minimally invasive surgical procedures. FGS systems enable surgeons to identify tumors, blood vessels, and other critical structures with high accuracy using fluorescent markers, improving surgical outcomes and reducing complications. The increasing prevalence of cancer worldwide is a key driver, as fluorescence-guided surgery is particularly beneficial in oncology for tumor delineation and complete excision. Additionally, advancements in fluorescence imaging technology, such as higher resolution and improved sensitivity, along with the adoption of robotic-assisted surgeries, further propel market growth. As patients and healthcare providers demand safer, more effective treatments, the market for FGS systems is expected to continue expanding.
However, the market also faces several challenges. One of the primary hurdles is the high cost of fluorescence-guided surgery systems, which can be a barrier to adoption, particularly in low-resource healthcare settings. Additionally, the technology requires specialized training for medical professionals to ensure its proper use, which adds to the operational complexity and costs. The regulatory approval process for fluorescence-based imaging agents can also be lengthy and costly, delaying the introduction of new treatments and technologies. Moreover, the integration of fluorescence-guided surgery systems with existing medical devices and hospital infrastructure can be challenging, limiting their widespread implementation, especially in smaller or less-equipped healthcare facilities.
Global key players of Fluorescence-Guided Surgery Systems include Stryker, Hamamatsu Photonics, Medtronic, Quest Medical Imaging, Shimadzu and Fluoptics, etc. Top two players occupy for a share about 70%. North America is the largest market, with a share about 63%, followed by Europe and China.
This report aims to provide a comprehensive presentation of the global market for Fluorescence-Guided Surgery Systems, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Fluorescence-Guided Surgery Systems by region & country, by Type, and by Application.
The Fluorescence-Guided Surgery Systems market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fluorescence-Guided Surgery Systems.
Market Segmentation
By Company
Stryker
Hamamatsu Photonics
Medtronic
Quest Medical Imaging
Shimadzu
Fluoptics
KARL STORZ
Richard Wolf
OptoMedic
Mindray
Olympus
Segment by Type
Only for Open Surgery
System for Endoscopy
Segment by Application
Cancer Surgeries
Cardiovascular Surgeries
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Fluorescence-Guided Surgery Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Fluorescence-Guided Surgery Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Fluorescence-Guided Surgery Systems in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Index